-

GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into GoodRx Holdings, Inc. (NasdaqGS: GDRX).

On September 23, 2020, the Company completed its initial public stock offering (“IPO”), selling about 34.6 million shares at $33.00 per share. On November 17, 2020, Amazon announced two new pharmacy offerings that would compete directly with the Company’s platform: a Prime Rx plan and a discount card program, which was said would make it “simple for customers to compare prices and purchase medications for home delivery, all in one place.”

The Company has been sued in a securities class action lawsuit for failing to disclose material information at the time of the IPO and during the class period, violating federal securities laws, which remains ongoing.

KSF’s investigation is focusing on whether GoodRx’s officers and/or directors breached their fiduciary duties to GoodRx’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of GoodRx shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-gdrx/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Industry:

Kahn Swick & Foti, LLC

NASDAQ:GDRX
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Scotts Miracle-Gro Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Scotts Miracle-Gro Company - SMG

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Scotts Miracle-Gro Company (NYSE: SMG) (“Scotts” or the “Company”). On August 2, 2023, the Company disclosed disappointing financial results including a decline in quarterly sales for fiscal third quarter of 6%, a decline in gross margin by 420 basis points, as well a...

Clearway Energy Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Clearway Energy, Inc. - CWEN

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--The law firm of Kahn Swick & Foti, LLC (“KSF”) has commenced an investigation into Clearway Energy, Inc. (NYSE: CWEN). KSF is investigating potential claims for breach of fiduciary duty against the board of directors of Clearway Energy, Inc. and its controlling stockholder, Clearway Energy Group LLC. If you hold shares of Clearway Energy, Inc. (NYSE: CWEN), we urge you to contact KSF to discuss your legal rights, without obligation or cost to yo...

Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NasdaqGS: OFIX).On September 12, 2023, the Company announced the appointment of an interim CEO, interim CFO, and interim CLO, effective immediately, following the “unanimous decision by the Board’s independent directors...
Back to Newsroom